Seroprevalence Hepatitis E Infection in Healthy Blood Donors
NCT ID: NCT03601221
Last Updated: 2020-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1447 participants
OBSERVATIONAL
2018-05-29
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exposure to Hepatitis E Virus in Occitania, France
NCT06137313
Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection
NCT01090232
Hepatitis E Virus Infection in Oncological Patients
NCT06631560
Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
NCT05976594
Hepatitis B and C Within the Chinese Community in Milan
NCT07241962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sample collection
Collection of one sampling pouch from each blood donor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects living in the Canton Ticino
* Signed informed consent of the STCRS SI for blood donation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Transfusion SRC
OTHER
Clinical Trial Unit Ente Ospedaliero Cantonale
OTHER
Ente Ospedaliero Cantonale, Bellinzona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florian Bihl, MD
Role: STUDY_DIRECTOR
Ente Ospedaliero Cantonale, Bellinzona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Swiss Transfusion SRC Canton Ticino
Lugano, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HEV-TI-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.